Okyo Pharma CEO purchases 10,000 shares of company

OKYO Pharma (OKYO) has been notified that the CEO Gary Jacob has purchased 10,000 of the Company’s ordinary shares on NASDAQ at a price of $1.04 per share. The company said, “We have also been notified that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman, has a beneficial interest, purchased 20,000 of the Company’s ordinary shares on NASDAQ at a price of $1.04 per share. This brings the total shareholding of Cerrone to 9,871,570 shares which is 28.96% of issued share capital.”